David Belowich

Digi Link Technologies, Inc. develops and operates 220 MHz analog wireless communications services and satellite license. The company was founded in January 1972 and is headquartered in Iselin, NJ.

Palms West Hospital LP provides health care services. The firm provides cardiopulmonary, cardiovascular, endoscopy, surgical, imaging, and rehabilitation services. It also provides blood pressure, glucose, cholesterol, pulmonary, pulse oximetry, body mass index, bone density, and managed care services. The company was founded in 1986 and is headquartered in Loxahatchee, FL.

Somerset Medical Center, Inc. provides medical and health care services. It offers diagnostic, emergency care, cardiology, maternity, outpatient, orthopedic, surgical and rehabilitation services. The company was founded on December 06, 1899 and is headquartered in Somerville, NJ.

Part of Magyar Bancorp, Inc., Magyar Bank is a financial institution based in New Brunswick, NJ. Magyar Bank offers a range of financial services, including affordable housing, auto and personal loans, mortgages, debit cards, and telephone banking. The bank also provides online banking services, educational resources on online security, and convenient branch locations. Magyar Bank is an SBA preferred lender and has been helping small businesses for over 100 years. The bank is committed to serving its community and offers home equity loans and lines of credit to help customers achieve their financial goals. John S. Fitzgerald has been the CEO of the company since 2001.

Telamon Corp. provides family and community services. It offers national frame worker jobs program (NFJP), housing, employee training, immigration and taxes. The company was founded in 1965 and is headquartered in Raleigh, NC.

G&W Laboratories, Inc. engages in the manufacturing and marketing pharmaceutical products. It offers generics and Rx products. The company was founded by Carl Greenblatt in 1919 and is headquartered in South Plainfield, NJ.

Hackensack Meridian Health, Inc. provides healthcare services. The firm offers ablative surgery, acute care of the elderly, adenocarcinoma, adult physicals, amputee program, amyotrophic lateral sclerosis, assisted living, at home health care services, audiology and axillary lymph node dissection. It comprises of hospitals, including academic medical centers, children?s hospitals and nine community hospitals, physician practices, ambulatory care centers, surgery centers, home health services, long-term care and assisted living communities, ambulance services, lifesaving air medical transportation, fitness, and wellness centers. The company was founded in July 2016 and is headquartered in Edison, NJ.

Kallyope, Inc. engages in developing drugs and consumer products. Its specialties include biotechnology, gut-brain axis, nutrition, and pharmaceuticals. The company was founded by Thomas P. Maniatis, Charles Zuker and Richard Axel in 2014 and is headquartered in New York, NY.

The Young Men's Christian Association of Metuchen New Jersey, also known as the YMCA of MEWSA, is an official charity partner of the 2023 TCS. The non-profit company is based in Metuchen, NJ. The company offers wellness services to individuals who are looking for direction, motivation, or new ideas to improve their health. The company's Y Wellness Staff provides personalized consultations to discuss health history, exercise experience, interests, goals, and options that individuals may not have considered.

NewPace Ltd. develops a novel implantable subcutaneous string defibrillator. It is used for the prevention of cardiac arrest. The company was founded by Robert S. Fishel in 2012 and is headquartered in Caesarea, Israel.

Apnimed, Inc. operates as a clinical-stage company. It discovers novel pharmaceutical therapies for sleep apnea and related disorders. The company was founded by Lawrence G. Miller and Luigi Taranto Montemurro in 2017 and is headquartered in Cambridge, MA.

Renaissance Properties, Inc. is a real estate brokerage company. The private company is based in Old Bridge, NJ. The CEO of the company is Robert McDaid.

Part of Nektar Therapeutics, Inheris Biopharma, Inc. operates as a biopharmaceutical company. The company is based in Chicago, IL.

The Discovery Labs LLC, a part of MLP Ventures, is a provider of world-class CGMP manufacturing, turnkey laboratory solutions, critical materials, and office space that support therapeutic products and services to the biotechnology and pharmaceutical industry. The private company is based in King of Prussia, PA, and was founded by Brian J. O'Neill and Audrey E. Greenberg. The location in eastern PA is a prototype for a rollout of the Discovery Labs, providing big pharma, emerging life sciences, consumer, and technology companies flexible, end-to-end technical real estate and business infrastructure for the customer's entire lifecycle from discovery to delivery, including manufacturing capacity. The company enables its partners to accelerate the manufacturing of life-changing, life-saving therapies. The Discovery Labs is the first fully integrated environment that merges technology and life sciences under one roof to drive innovation. The company offers move-in ready spaces for turnkey cell and gene therapy laboratory, office, or manufacturing space experience. The Innovation Renaissance campus is split up into 14 office, pharma quality, FDA lab, and last-mile distribution buildings on 80 acres equipped with walking trails, fitness, a daycare, and brew pub for all tenants.

FluidForm, Inc. is a company based in Waltham, MA. FluidForm is the world leader in functional human tissue for research, repair, and replacement. FluidForm, Inc. has developed a patented fresh 3D printing technology that is considered the most advanced biofabrication platform in the world. The company's robust pipeline includes the development of bioprosthetic implantable medical devices and a new generation of tissue models to test drug efficacy and cardiotoxicity. The company's ultimate focus is on tissue and organ replacement. FluidForm is transforming regenerative medicine by 3D bioprinting human tissue for drug discovery, surgical repair, and organ transplant. The company was founded in 2018 by Adam Feinberg and Mike Graffeo. Mike Graffeo has been the CEO of the company since 2018.